OBJECTIVE: To examine patient and physician preferences in regard to 5 colorectal cancer screening alternatives endorsed by a 1997 expert panel, determine the impact of patient and physician values regarding certain test features on screening preference, and assess physicians' perceptions of patients' values. DESIGN: Cross-sectional survey. SETTING: A general internal medicine practice at an academic medical center in 1998. PARTICIPANTS: Patients (N=217; 76% response rate) and physicians (N=39; 87% response rate) at the study setting. MEASUREMENTS AND MAIN RESULTS: Patients preferred fecal occult blood testing (43%) or colonoscopy (40%). In patients for whom accuracy was the most important test feature, colonoscopy (62%) was the preferred screening method. Patients for whom invasive test features were more important preferred fecal occult blood testing (76%; P <.001). Patients and physicians were similar in their values regarding the various test features. However, there was a significant difference between physicians' perceptions of which test features were important to patients compared with the patients' actual responses (P <.001). The largest discrepancy was for accuracy (patient actual 54% vs physician opinion 15%) and discomfort (patient actual 15% vs physician opinion 64%). CONCLUSIONS: Patients have distinct preferences for colorectal cancer screening tests that are associated with the importance placed on certain test features. Physicians incorrectly perceive those factors that are important to patients. Physicians should incorporate patient values in regard to certain test features when discussing colorectal cancer screening with their patients and when eliciting their screening preferences.
OBJECTIVE: To examine patient and physician preferences in regard to 5 colorectal cancer screening alternatives endorsed by a 1997 expert panel, determine the impact of patient and physician values regarding certain test features on screening preference, and assess physicians' perceptions of patients' values. DESIGN: Cross-sectional survey. SETTING: A general internal medicine practice at an academic medical center in 1998. PARTICIPANTS: Patients (N=217; 76% response rate) and physicians (N=39; 87% response rate) at the study setting. MEASUREMENTS AND MAIN RESULTS:Patients preferred fecal occult blood testing (43%) or colonoscopy (40%). In patients for whom accuracy was the most important test feature, colonoscopy (62%) was the preferred screening method. Patients for whom invasive test features were more important preferred fecal occult blood testing (76%; P <.001). Patients and physicians were similar in their values regarding the various test features. However, there was a significant difference between physicians' perceptions of which test features were important to patients compared with the patients' actual responses (P <.001). The largest discrepancy was for accuracy (patient actual 54% vs physician opinion 15%) and discomfort (patient actual 15% vs physician opinion 64%). CONCLUSIONS:Patients have distinct preferences for colorectal cancer screening tests that are associated with the importance placed on certain test features. Physicians incorrectly perceive those factors that are important to patients. Physicians should incorporate patient values in regard to certain test features when discussing colorectal cancer screening with their patients and when eliciting their screening preferences.
Authors: J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman Journal: N Engl J Med Date: 2000-11-30 Impact factor: 91.245
Authors: R A Smith; A C von Eschenbach; R Wender; B Levin; T Byers; D Rothenberger; D Brooks; W Creasman; C Cohen; C Runowicz; D Saslow; V Cokkinides; H Eyre Journal: CA Cancer J Clin Date: 2001 Jan-Feb Impact factor: 508.702
Authors: Sarah T Hawley; Amy McQueen; L Kay Bartholomew; Anthony J Greisinger; Sharon P Coan; Ronald Myers; Sally W Vernon Journal: Cancer Date: 2011-09-21 Impact factor: 6.860
Authors: Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea Journal: Am J Public Health Date: 2006-10-31 Impact factor: 9.308
Authors: Sumedha V Chablani; Noah Cohen; Drusilla White; Steven H Itzkowitz; Katherine DuHamel; Lina Jandorf Journal: J Immigr Minor Health Date: 2017-10
Authors: Susan A Flocke; Kurt C Stange; Gregory S Cooper; Tracy L Wunderlich; Nancy Oja-Tebbe; George Divine; Jennifer Elston Lafata Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-08-03 Impact factor: 4.254
Authors: Jennifer Elston Lafata; Gregory S Cooper; George Divine; Susan A Flocke; Nancy Oja-Tebbe; Kurt C Stange; Tracy Wunderlich Journal: Am J Prev Med Date: 2011-11 Impact factor: 5.043
Authors: Ann C DeBourcy; Scott Lichtenberger; Susanne Felton; Kiel T Butterfield; Dennis J Ahnen; Thomas D Denberg Journal: J Gen Intern Med Date: 2007-12-21 Impact factor: 5.128